More fair, reliable criteria needed for cost-effectiveness of antihypertensive agents

Published: 2010-04-12 06:57:00

Updated: 2010-04-12 06:57:00

The government will have to undertake controversial drug pricing and reimbursement policies despite opposition from pharmaceutical companies, according to the Korean Pharmacists for Democratic Society.

The civic group said in a recent statement that the Health Insurance Review and Assessment S...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK